OBJECTIVES: This study assessed seroprevalence rates of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) among individuals with severe mental illness. METHODS: Participants (n = 931) were patients undergoing inpatient or outpatient treatment in Connecticut, Maryland, New Hampshire, or North Carolina. RESULTS: The prevalence of HIV infection in this sample (3.1%) was approximately 8 times the estimated US population rate but lower than rates reported in previous studies of people with severe mental illness. Prevalence rates of HBV (23.4%) and HCV (19.6%) were approximately 5 and 11 times the overall estimated population rates for these infections, respectively. CONCLUSIONS: Elevated rates of HIV, HBV, and HCV were found. Of particular concern are the high rates of HCV infection, which are frequently undetected. Individuals with HCV infection commonly fail to receive appropriate treatment to limit liver damage and unknowingly may be a source of infection to others.
OBJECTIVES: This study assessed seroprevalence rates of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) among individuals with severe mental illness. METHODS:Participants (n = 931) were patients undergoing inpatient or outpatient treatment in Connecticut, Maryland, New Hampshire, or North Carolina. RESULTS: The prevalence of HIV infection in this sample (3.1%) was approximately 8 times the estimated US population rate but lower than rates reported in previous studies of people with severe mental illness. Prevalence rates of HBV (23.4%) and HCV (19.6%) were approximately 5 and 11 times the overall estimated population rates for these infections, respectively. CONCLUSIONS: Elevated rates of HIV, HBV, and HCV were found. Of particular concern are the high rates of HCV infection, which are frequently undetected. Individuals with HCV infection commonly fail to receive appropriate treatment to limit liver damage and unknowingly may be a source of infection to others.
Authors: J A Kelly; T L McAuliffe; K J Sikkema; D A Murphy; A M Somlai; G Mulry; J G Miller; L Y Stevenson; M I Fernandez Journal: Psychiatr Serv Date: 1997-10 Impact factor: 3.084
Authors: V Di Nardo; N Petrosillo; G Ippolito; M E Bonaventura; V Puro; B Chiaretti; M Tosoni Journal: Eur J Epidemiol Date: 1995-04 Impact factor: 8.082
Authors: G Barbaro; G Di Lorenzo; G Belloni; L Ferrari; A Paiano; P Del Poggio; D Bacca; L Fruttaldo; F Mongiò; R Francavilla; G Scotto; B Grisorio; G Calleri; M Annese; A Barelli; P Rocchetto; G Rizzo; G Gualandi; I Poltronieri; G Barbarini Journal: Am J Med Date: 1999-08 Impact factor: 4.965
Authors: Marjorie J Robertson; Richard A Clark; Edwin D Charlebois; Jacqueline Tulsky; Heather L Long; David R Bangsberg; Andrew R Moss Journal: Am J Public Health Date: 2004-07 Impact factor: 9.308
Authors: James Walkup; Ayse Akincigil; Donald R Hoover; Michele J Siegel; Shahla Amin; Stephen Crystal Journal: Public Health Rep Date: 2011 Sep-Oct Impact factor: 2.792
Authors: Michael B Blank; Seth S Himelhoch; Alexandra B Balaji; David S Metzger; Lisa B Dixon; Charles E Rose; Emeka Oraka; Annet Davis-Vogel; William W Thompson; James D Heffelfinger Journal: Am J Public Health Date: 2014-02-13 Impact factor: 9.308
Authors: John A Encandela; Wynne S Korr; Kathleen Hulton; Gary F Koeske; W Dean Klinkenberg; Laura L Otto-Salaj; Anthony J Silvestre; Eric R Wright Journal: J Behav Health Serv Res Date: 2003 Oct-Dec Impact factor: 1.505